Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.
about
Comparison of amplification enzymes for Hepatitis C Virus quasispecies analysisWide range of quasispecies diversity during primary hepatitis C virus infectionPlasma and Liver Hepatitis C Virus Variability in Patients Coinfected with Human Immunodeficiency VirusTherapeutic issues in HIV/HCV-coinfected patientsInfluence of increased CD4 cell counts on the genetic variability of hepatitis C virus in patients co-infected with human immunodeficiency virus IBaseline CD4 Cell Count and Outcome of Pegylated Interferon Plus Ribavirin Therapy in HIV/Hepatitis C Virus-Coinfected PatientsCoinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical OutcomesDistribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalised in bydgoszcz.Within-host dynamics of the hepatitis C virus quasispecies population in HIV-1/HCV coinfected patients.Trends for genetic variation of Hepatitis C Virus quasispecies in Human Immunodeficiency virus-1 coinfected patientsThe hepatitis C virus 5'UTR genomic region remains highly conserved under HAART: a 4- to 8-year longitudinal study from HCV/HIV co-infected patientsHepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfectionHepatitis C virus protease gene diversity in patients coinfected with human immunodeficiency virusGenetic divergence of hepatitis C virus: the role of HIV-related immunosuppression.Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.Hepatitis C virus quasispecies in HIV-infected women: role of injecting drug use and highly active antiretroviral therapy (HAART)Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1.Effect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.Los Alamos hepatitis C virus sequence and human immunology databases: an expanding resource for antiviral research.
P2860
Q24800738-39A88086-562D-4266-BDEA-23D4AE765D29Q27469430-5FCCAF5C-6B00-4C54-B9F8-A1BB03136F13Q27473249-C3047641-850F-4D00-BD5C-C31717E2EB1CQ27481053-C29F8438-F8BF-4DC5-88D2-15F9F2D10531Q27485710-A8BCE8B6-758B-44B8-86AC-0DC9F86428DEQ27485951-86C54D4F-6567-4BD6-A6C4-1A9BCAE861D0Q27488883-42F1C594-79DB-4BCB-A491-0DB22C9A7D5CQ33647250-D0478707-EEA6-49B2-8BEC-0AD1FDDE8ACAQ33815695-4D25EF61-4E42-4D5E-BA4C-1368109A25D4Q34058230-5DEA4064-B3F1-4B1D-AC37-4A3E4EDB8879Q34103186-3031D7AE-BD44-419C-9091-869019A443A4Q34298877-8A9B16EB-7C1F-4D70-ACCE-3616ADD54F75Q34545969-24D48301-2F1F-4B38-B770-7E9E3FD5F30CQ34764615-9F80084E-CC68-433F-B7ED-5219CDF98479Q36088274-9125A02E-C7BF-40C3-9166-D57F6D5AF904Q36427909-98EA3A69-39CC-4E84-9EB3-81C0192DBA43Q37511130-8AAF801E-6CC2-4CDC-8E68-63A4EA9B0244Q42993493-C24E8260-8D9A-48D9-86B7-6BBF28CC22C5Q43039202-BF4E22DE-1FD3-477F-A965-5DCBF085C886
P2860
Impact of highly active antiretroviral therapy and immunologic status on hepatitis C virus quasispecies diversity in human immunodeficiency virus/hepatitis C virus-coinfected patients.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Impact of Highly Active Antire ...... is C Virus-Coinfected Patients
@nl
Impact of highly active antire ...... s C virus-coinfected patients.
@ast
Impact of highly active antire ...... s C virus-coinfected patients.
@en
type
label
Impact of Highly Active Antire ...... is C Virus-Coinfected Patients
@nl
Impact of highly active antire ...... s C virus-coinfected patients.
@ast
Impact of highly active antire ...... s C virus-coinfected patients.
@en
prefLabel
Impact of Highly Active Antire ...... is C Virus-Coinfected Patients
@nl
Impact of highly active antire ...... s C virus-coinfected patients.
@ast
Impact of highly active antire ...... s C virus-coinfected patients.
@en
P2860
P1433
P1476
Impact of highly active antire ...... s C virus-coinfected patients.
@en
P2093
Jennifer M Babik
P2860
P304
P356
10.1128/JVI.77.3.1940-1950.2003
P577
2003-02-01T00:00:00Z